- Home
- Article
- Mergers & Acquisitions
- Ayurveda doctor platform NirogStreet buys Brahm Ayurved
NirogStreet, an online platform that connects ayurveda doctors with patients, has acquired Brahm Ayurved, a 60,000 member-strong community of ayurvedic doctors, a media statement said.
Post the deal, Gupta will join NirogStreet as co-founder and chief marketing officer, the statement added. Gupta worked as a clinician and an advisor at Apollo Pharmacy in the past.
Operated by Wellbeing Healthtech Pvt. Ltd, NirogStreet was founded in 2016 by Ram N Kumar, Aradhna Rai and Shrey Jain.
“Brahm Ayurved has created an active and quality platform for discussion and knowledge exchange which will enable us to achieve our goals. Ayurveda is a rich science and has a lot of potential as a primary healthcare option for not just India but the world,” Kumar said.
The company said its objective is to make ayurveda evidence-based do that it is the first line of treatment for people. NirogStreet also collaborates with experts, practitioners, and organisations to conduct continuing medical education and discussion sessions.
The company has developed a ‘NirogStreet for Ayurveda Doctors’ app, where users can make appointments with doctors. The app also aims to build an interactive and information-sharing platform for practitioners, academicians, and students.
It claims to have over 15,000 doctors on the platform and is looking to raise pre-Series A funds this year.
Last month, NirogStreet raised $300,000 (Rs 2 crore) in a seed round led by Japanese venture capital firm Spiral Ventures. Others who took part in the round were Subho Ray, president of the Internet and Mobile Association of India; and Samir Kumar, derivatives director at Deutsche Bank in Singapore.
Founded by Abhishek Gupta in 2010, Brahm Ayurved brings together ayurveda experts and students on a single platform to promote learning, knowledge sharing, employment opportunities, and industry updates on its portal. It also publishes a digital bi-monthly Ayurveda magazine in Hindi.